Fidelity MSCI Health Care Index ETF
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Latest news
All FHLC news ›Precision BioSciences Announces Pricing of $125 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
Precision BioSciences, Inc., a clinical stage gene editing company utilizing its novel proprietary ARCUS ® platform to develop in vivo gene editing therapies for high unmet need diseases, today announced the pricing of an underwritten…
LifeMD expands access to Lilly’s self-pay GLP-1 medicines, enabling option to dispense and ship directly to patients nationwide
NEW YORK, Nov. 05, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care, today announced an arrangement with Eli Lilly and Company (Lilly) that enables LifeMD's affiliated pharmacy to directly…
Four undervalued healthcare stocks with the highest year-over-year CapEx growth
Explore 4 healthcare stocks with rising CapEx and attractive valuations as investors navigate earnings, policy uncertainty, and sector shifts. iQoncept/iStock via Getty Images Amid a mixed and cautious backdrop for the US stock market,…
Prediction: The Weight-Loss Drug Boom Could Be Just the Beginning for Lilly
Eli Lilly just crushed earnings and raised guidance, yet the most compelling part of its story has almost nothing to do with what already happened. The real question is whether the weight-loss boom is a peak or a launching pad… Eli Lilly…
Nova Sets November 5 Release Date for Q3 2026 Results
Nova ( (NVMI) ) just unveiled an update. The most recent analyst rating on (NVMI) stock is a Hold with a $415.00 price target. To see the full list of analyst forecasts on Nova stock, see the NVMI Stock Forecast page. Spark’s Take on NVMI…
RBC Capital Remains a Buy on Shake Shack (SHAK)
RBC Capital analyst Logan Reich maintained a Buy rating on Shake Shack yesterday and set a price target of $89.00. Reich covers the Consumer Cyclical sector, focusing on stocks such as McDonald’s, Restaurant Brands International, and CAVA…
Cardinal Health Q1 2027: EPS beats by 11%, CVS deal secured
As seen on the 24/7 Wall St. homepage on November 5, 2026. Full-year guidance went up to $12.80 to $13.00 per share, and management locked in a binding letter of intent to renew its CVS Health distribution agreements, removing the biggest…
Oscar Health Profits Hit $167 Million En Route To ‘Strongest Year’
Health insurer Oscar Health swung to a $167 million third quarter profit while eclipsing $1.2 billion in net income for the first nine months as health plan membership grows and the company gets a handle on medical costs. Oscar, which has…
Cigna Profits Hit $1.4 Billion As Health Insurer Controls Costs
The Cigna Group reported third quarter net income of $1.4 billion as the company maintains a handle on its medical costs, triggering an improved financial outlook. Cigna Profits Hit $1.4 Billion As Health Insurer Controls Costs The Cigna…
Akebia Therapeutics reports noninferiority in vadadustat dosing trial
A three-times-weekly vadadustat regimen met a Phase 3 hemoglobin target as Akebia Therapeutics, Inc. NASDAQAKBA reported positive dosing results on Thursday. The 353-patient VOCAL trial adds efficacy evidence for a schedule that remains…
From the 4Search news index, newest first.